肌层浸润性膀胱癌手术与放化疗的碳足迹及人员需求
本研究量化了肌层浸润性膀胱癌两种完整治疗路径(根治性膀胱切除术与放化疗)的总碳足迹和人员需求。根治性膀胱切除术碳足迹为208 kg CO2当量,放化疗为264 kg CO2当量;根治性膀胱切除术平均每患者93.5人员小时,放化疗为29.0人员小时。
要点
- 放化疗碳足迹高于根治性膀胱切除术,主要因患者出行和能源使用。
- 根治性膀胱切除术碳足迹主要贡献者为医疗产品(49%)。
- 根治性膀胱切除术人员需求显著高于放化疗(93.5 vs 29.0小时/患者)。
核心结论
- 根治性膀胱切除术碳足迹为208 kg CO2当量,放化疗为264 kg CO2当量。
- 根治性膀胱切除术平均每患者93.5人员小时,放化疗为29.0人员小时。
研究设计与样本
- 计算肌层浸润性膀胱癌两种完整治疗路径(根治性膀胱切除术与放化疗)的碳足迹和人员需求。
- 根治性膀胱切除术为机器人辅助手术加盆腔淋巴结清扫和回肠导管。
- 放化疗包括20次2/2.75 Gy放疗,第1天丝裂霉素C,每个放疗日卡培他滨。
- 废物审计识别284种医疗产品,进行从摇篮到大门的环境影响分析。
- 能源使用基于原始数据、技术规格或文献;患者出行基于平均距离,假设汽油车。
主要发现
- 放化疗碳足迹较大源于出行和能源使用,分别比根治性膀胱切除术高5倍和1.5倍。
- 根治性膀胱切除术总碳足迹主要贡献者为医疗产品(49%)。
- 放化疗总碳足迹主要贡献者为患者出行(74%)。
- 热点分析识别10种医疗产品,占所有医疗产品总影响的60%。
临床怎么用
- 减少肌层浸润性膀胱癌治疗碳足迹的策略包括低影响患者出行、审查高影响手术产品、医院使用可再生能源。
- 了解每治疗的人员需求有助于高效分配稀缺人员。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To calculate the environmental and labour impact of two complete care pathways for patients with muscle-invasive bladder cancer (MIBC) with similar oncological outcomes: radical cystectomy (RC) and chemoradiation (CRT), by quantifying the total carbon footprint and staff demands. PATIENTS AND METHODS: The RC was robot-assisted surgery with pelvic lymph node dissection and ileal conduit. CRT included 20 fractions of 2/2.75 Gy with mitomycin C (Day 1) and capecitabine every radiation day. Waste audits identified medical products (n = 284), for which a cradle-to-gate environmental impact analysis was conducted from treatment selection to first post-treatment evaluation. Energy use was based on primary data, technical specifications or literature. Patient travel was based on the average distance, assuming petrol-fuelled cars. Staff demands were assessed by timing clinical staff assignment. The carbon footprint was calculated in CO2-equivalents using the Ecoinvent Database 3.10. RESULTS: The carbon footprint was 208 kg CO2-equivalents for RC vs 264 kg CO2-equivalents for CRT. The larger footprint of CRT arose from travel movements and energy use: 5- and 1.5-fold higher than RC, respectively. Main contributors to the total footprint were medical products for RC (49%), and patient travel for CRT (74%). A hotspot analysis identified 10 medical products with the highest impact, which accounted for 60% of the total impact of all medical products. RC averaged 93.5 staff hours per patient vs 29.0 staff hours per patient for CRT. CONCLUSIONS: This is the first study to analyse the environmental impact of complete care pathways in uro-oncology. Key strategies to reduce the carbon footprint of MIBC treatment include low-impact patient travel, reviewing high-impact surgical products, and using renewable energy by hospitals. Insight into staff demands per treatment assists efficient allocation of scarce personnel.
引用
- Rutten VC, Hesseling SAW, Franckena M, et al. Carbon footprint and staff demands of surgery and chemoradiation for muscle-invasive bladder cancer. BJU Int. 2025. PMID: 40899373. doi:10.1111/bju.16876
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。